277 related articles for article (PubMed ID: 19387588)
21. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
Sathisha MP; Budagumpi S; Kulkarni NV; Kurdekar GS; Revankar VK; Pai KS
Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
[TBL] [Abstract][Full Text] [Related]
23. Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Noaman E; Ghorab MM
Eur J Med Chem; 2010 Feb; 45(2):738-44. PubMed ID: 19944497
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
[TBL] [Abstract][Full Text] [Related]
25. [The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
Xie QJ; Zhang X; Wang X; Bai L; Li HY
Zhong Yao Cai; 2009 Jun; 32(6):933-6. PubMed ID: 19764334
[TBL] [Abstract][Full Text] [Related]
26. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effect of avermectins.
Drinyaev VA; Mosin VA; Kruglyak EB; Novik TS; Sterlina TS; Ermakova NV; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
Eur J Pharmacol; 2004 Oct; 501(1-3):19-23. PubMed ID: 15464058
[TBL] [Abstract][Full Text] [Related]
28. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
[TBL] [Abstract][Full Text] [Related]
29. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
30. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice.
Jagetia GC; Baliga MS; Venkatesh P; Ulloor JN; Mantena SK; Genebriera J; Mathuram V
J Pharm Pharmacol; 2005 Sep; 57(9):1213-9. PubMed ID: 16105243
[TBL] [Abstract][Full Text] [Related]
32. Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma.
Verma AK; Prasad SB
Cell Biol Toxicol; 2012 Jun; 28(3):133-47. PubMed ID: 22402807
[TBL] [Abstract][Full Text] [Related]
33. In vivo anti-tumour activity of novel Quinazoline derivatives.
Alapati V; Noolvi MN; Manjula SN; Pallavi KJ; Patel HM; Tippeswamy BS; Satyanarayana SV
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(13):1753-64. PubMed ID: 23208959
[TBL] [Abstract][Full Text] [Related]
34. 2,3-Disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazolines: a novel class of antitumor agents.
Zhang Y; Chen Z; Lou Y; Yu Y
Eur J Med Chem; 2009 Jan; 44(1):448-52. PubMed ID: 18313807
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA
Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162
[TBL] [Abstract][Full Text] [Related]
36. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity and antioxidant role of a novel water-soluble carboxymethyl chitosan-based copolymer.
El-Far M; Elshal M; Refaat M; El-Sherbiny IM
Drug Dev Ind Pharm; 2011 Dec; 37(12):1481-90. PubMed ID: 21707234
[TBL] [Abstract][Full Text] [Related]
38. Possible anticancer agents: QSAR analogs of glutamamide: synthesis and pharmacological activity of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides.
Samanta S; Alam SM; Panda P; Jha T
Eur J Med Chem; 2009 Jan; 44(1):70-82. PubMed ID: 18456372
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
Sanyal U; Dutta S; Das H
Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
